Underlying Data
2171 CARSGEN-B
11.21
+0.390
(+3.60%)
Bid: 11.16
Ask: 11.21
10.92
15.33M
6.43B
11.21
10.82
1.42M
-57.92
10.47
10.80
500
0.00 %
57.25
10.02
10.92
10.82
15.33M
1.42M
6.43B
-57.92
11.21
10.47
500
0.00 %
57.25
10.02
10.80
Description: CARSGEN is a Chinese innovative pharmaceutical company focused on developing CAR-T cell therapies for the treatment of hematologic malignancies and solid tumors.
Industry: Pharma
Last Updated:23-10-26 16:20 (15 minutes delayed)
Similar Product
Information Provided by DB Power Online Limited
[Disclaimer]